A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants

Clinical trial NCT06889701 · RECRUITING

Trial details

NCT number: NCT06889701
Sponsor: TenNor Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Periprosthetic Joint Infection (PJI)

Start date: 2025-04-03
Primary completion: 2026-08-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.